Ryan Specialty Holdings Inc. (NYSE:RYAN) Given Average Rating of “Moderate Buy” by Brokerages

Ryan Specialty Holdings Inc. (NYSE:RYAN) has received an average recommendation of “Moderate Buy” from the sixteen ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $59.40.

RYAN has been the topic of a number of research reports. Weiss Ratings cut Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. BMO Capital Markets dropped their price objective on shares of Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. The Goldman Sachs Group set a $61.00 target price on shares of Ryan Specialty in a research note on Wednesday, January 7th. Finally, Morgan Stanley set a $61.00 price target on shares of Ryan Specialty in a research note on Tuesday, December 16th.

Ryan Specialty Stock Performance

NYSE:RYAN opened at $41.36 on Friday. The firm’s 50-day moving average is $48.85 and its 200-day moving average is $53.32. The company has a market cap of $10.91 billion, a price-to-earnings ratio of 98.49, a PEG ratio of 1.07 and a beta of 0.62. The company has a debt-to-equity ratio of 2.62, a quick ratio of 1.00 and a current ratio of 0.98. Ryan Specialty has a 52-week low of $37.29 and a 52-week high of $77.16.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The company’s revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.45 earnings per share. Equities research analysts anticipate that Ryan Specialty will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be paid a $0.13 dividend. The ex-dividend date of this dividend is Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.3%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. Ryan Specialty’s payout ratio is presently 123.81%.

Insiders Place Their Bets

In other Ryan Specialty news, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the completion of the transaction, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. This represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 52.21% of the stock is owned by company insiders.

Institutional Investors Weigh In On Ryan Specialty

Several institutional investors and hedge funds have recently made changes to their positions in RYAN. T. Rowe Price Investment Management Inc. lifted its holdings in Ryan Specialty by 79.9% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock valued at $389,910,000 after purchasing an additional 3,353,926 shares during the last quarter. Invesco Ltd. raised its stake in shares of Ryan Specialty by 34.7% in the fourth quarter. Invesco Ltd. now owns 278,583 shares of the company’s stock valued at $14,383,000 after acquiring an additional 71,699 shares during the last quarter. Corient Private Wealth LLC boosted its holdings in shares of Ryan Specialty by 5.0% in the 4th quarter. Corient Private Wealth LLC now owns 17,807 shares of the company’s stock worth $919,000 after acquiring an additional 840 shares in the last quarter. Alberta Investment Management Corp bought a new stake in Ryan Specialty during the 4th quarter worth approximately $1,373,000. Finally, Vident Advisory LLC increased its holdings in Ryan Specialty by 11.0% during the 4th quarter. Vident Advisory LLC now owns 5,338 shares of the company’s stock valued at $276,000 after purchasing an additional 529 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.